Momenta Pharmaceuticals, Inc. News Headlines

MNTA 
$11.42
*  
0.06
0.52%
Get MNTA Alerts
*Delayed - data as of Dec. 24, 2014  -  Find a broker to begin trading MNTA now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Hold On To Teva!
12/22/2014 3:09:00 PM - Seeking Alpha


Momenta's Necuparanib Gets Fast Track Status in the U.S. - Analyst Blog
12/2/2014 3:10:00 PM - Zacks.com


Momenta Pharma. To Present At Deutsche Bank BioFEST; Webcast At 1:40 PM ET
12/1/2014 12:42:00 PM - RTT News


Momenta Pharma: Necuparanib Granted Fast Track Designation - Quick Facts
12/1/2014 8:20:00 AM - RTT News


Biosimilars: The Good, the Bad and the Unknown -- Barron's
11/6/2014 7:42:00 AM - Dow Jones Business News


Momenta Pharmaceuticals, Inc. Pushes Forward
11/5/2014 2:32:06 PM - Motley Fool


Weakness Seen in Momenta Pharmaceuticals (MNTA): Stock Tumbles 13.5% - Tale of the Tape
10/13/2014 7:30:00 AM - Zacks.com


Momenta Reveals Necuparanib Data for Pancreatic Cancer - Analyst Blog
10/10/2014 3:45:00 PM - Zacks.com


Momenta Pharmaceuticals 2014 R&D Day; Webcast At 8:30 AM ET
10/10/2014 7:30:00 AM - RTT News


Anika Therapeutics: A Recent Greenblatt Small Cap Biotech Pick
9/16/2014 8:38:00 AM - Seeking Alpha


Momenta Gains on Purchase of Autoimmune Antibodies - Analyst Blog
9/11/2014 4:45:00 PM - Zacks.com


Teva Proves You Cannot Escape The Patent Cliff
9/4/2014 9:47:00 AM - Seeking Alpha


Momenta-Sandoz's Generic Copaxone Accepted for Review by FDA - Analyst Blog
8/29/2014 2:20:00 PM - Zacks.com


Momenta Pharmaceuticals Heading For A Repeat
8/5/2014 8:15:00 AM - Seeking Alpha


2nd Half Of 2014 Biotechnology Catalysts-Part 3
8/4/2014 2:36:00 PM - Seeking Alpha


Momenta Posts Narrower Q2 Loss, Revenues Up Y/Y, Shares Gain - Analyst Blog
8/4/2014 10:50:00 AM - Zacks.com


Earnings Estimates Moving Higher for Momenta Pharmaceuticals (MNTA): Time to Buy? - Tale of the Tape
6/20/2014 7:42:00 AM - Zacks.com


Pipeline Progress at Momenta - Analyst Blog
6/9/2014 5:35:00 PM - Zacks.com


Mylan Gains Slightly on Copaxone News - Analyst Blog
5/16/2014 10:40:00 AM - Zacks.com


Narrower-than-Expected Loss at Momenta - Analyst Blog
5/7/2014 11:10:01 AM - Zacks.com


Momenta Pharmaceuticals Has Value In The Sum Of The Drugs
4/29/2014 10:35:00 AM - Seeking Alpha


Supreme Court Denies Teva's Request - Analyst Blog
4/21/2014 3:35:01 PM - Zacks.com


Healthcare Stocks Continue Rebound; Momenta Pharma Advances After Supreme Court OKs Generic MS Drug Sales
4/21/2014 12:22:11 PM - MT Newswires


Sector Update: Healthcare
4/21/2014 12:05:58 PM - MT Newswires


Mid-Morning Market Update: Markets Rise; Halliburton Posts Q1 Profit
4/21/2014 9:27:40 AM - Benzinga